Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pillebout, E.
Right arrow Articles by Nochy, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pillebout, E.
Right arrow Articles by Nochy, D.
J Am Soc Nephrol 13:1271-1278, 2002
© 2002 American Society of Nephrology

Henoch-Schönlein Purpura in Adults: Outcome and Prognostic Factors

Evangéline Pillebout*, Eric Thervet{dagger}, Gary Hill{ddagger}, Corinne Alberti§, Philippe Vanhille|| and Dominique Nochy

*INSERM U426, Faculté de Médecine X. Bichat, Université Paris 07, Paris, France; {dagger}Nephrology and Renal Transplant Unit, Hôpital Saint Louis, Paris, France; {ddagger}Nephrology and Renal Transplant Unit, Hôpital Européen George Pompidou, Paris, France; §Department of Biostatistics, Hôpital Saint Louis, Paris, France; ||Nephrology and Renal Transplant, Hôpital de Valenciennes, France; Pathology Unit, Hôpital Européen George Pompidou, Paris, France.

Correspondence to: Dr. Evangéline Pillebout, INSERM U426, Faculté de Médecine Xavier Bichat, 16, rue Henri Huchard BP416, 75870 Paris cedex 18, France. Phone: 33-1-44-85-62-70; Fax: 33-1-42-28-15-64; E-mail: pillebou{at}bichat.inserm.fr

ABSTRACT. Henoch-Schönlein Purpura nephritis (HSPN) has been extensively studied in children but, its natural history in adults is much less known. A cohort of 250 adults suffering HSP was retrospectively analyzed for a median follow-up period of 14.8 yr. All patients had biopsies consistent with HSP (predominant IgA mesangial deposits) associated with purpura, bowel angina, and/or abdominal pain. At presentation, palpable purpura was present in 96% of patients, and arthritis was reported in 61%, and gastrointestinal involvement in 48%. Thirty-two percent of the patients showed renal insufficiency (Creatinine clearance [CrCl] <50 ml/min), usually associated with proteinuria (99%) and/or hematuria (93%). Endocapillary glomerulonephritis was the most frequent lesion on renal biopsy (61%). At the end of follow-up, patient survival was only 74%. The first cause of death was carcinoma (most of them of respiratory or digestive tract). Regarding renal function, 11% of patients reached end-stage renal failure, 13% exhibited severe renal failure (CrCl <30 ml/min), and 14% moderate renal insufficiency (CrCl <50 ml/min). Clinical remission defined as the absence of proteinuria, hematuria, and a normal renal function was achieved in only 20%. This is a retrospective study; therefore, it is not possible to demonstrate any steroid and/or cyclophosphamide efficacy in diminishing the incidence of renal insufficiency. Multivariate analysis demonstrated that renal function impairment and proteinuria level at presentation and, on renal biopsy, the degree of interstitial fibrosis, percentage of sclerotic glomeruli, and presence of glomeruli with fibrinoid necrosis were associated with a poor renal prognosis. The data indicate that clinical presentation of HSPN in adults is severe and its outcome relatively poor, worse than in children. Identification of clinical and histologic prognostic factors may permit the design of appropriate therapeutic prospective studies.




This article has been cited by other articles:


Home page
NDT PlusHome page
K. Chaudhary, J.-Y. Shin, G. Saab, and A. M. Luger
Successful treatment of Henoch-Schonlein purpura nephritis with plasma exchange in an adult male
NDT Plus, October 1, 2008; 1(5): 303 - 306.
[Abstract] [Full Text] [PDF]


Home page
Age AgeingHome page
N. K. Gatselis, S. Barbanis, F. Karasavidou, and G. N. Dalekos
Could the 90s be a second childhood period? The case of Henoch-Schonlein purpura
Age Ageing, July 1, 2008; 37(4): 483 - 483.
[Full Text] [PDF]


Home page
NEJMHome page
M. D. Denton, S. R. Digumarthy, S. Chua, and R. B. Colvin
Case records of the Massachusetts General Hospital. Case 20-2006. An 84-year-old man with staphylococcal bacteremia and renal failure.
N. Engl. J. Med., June 29, 2006; 354(26): 2803 - 2813.
[Full Text] [PDF]


Home page
QJMHome page
S. Shrestha, N. Sumingan, J. Tan, H. Althous, L. McWilliam, and F. Ballardie
Henoch Schonlein purpura with nephritis in adults: adverse prognostic indicators in a UK population.
QJM, April 1, 2006; 99(4): 253 - 265.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. Kassutto and M. A. Wolf
A Wrinkle in Time
N. Engl. J. Med., August 7, 2003; 349(6): 597 - 601.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. Floege
Recurrent glomerulonephritis following renal transplantation: an update
Nephrol. Dial. Transplant., July 1, 2003; 18(7): 1260 - 1265.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP